指紋
過去五年中的合作和熱門研究領域
概要
-
-
靶向MIR31HG/LncHIFCAR 相關分子網絡在胰腺癌轉移和腫瘤微環境的研究－靶向致癌性非編碼核醣核酸 MIR31HG/miR-31分子調控網絡以增進胰臟癌治療效果(3/3)
Hsieh, Y.-Y. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
針對BTK/BCL2L11 axis的雙重標的對順鉑頑固型耐藥食道癌細胞的意義
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
SLOG versus modified FOLFIRINOX as first-line treatment for advanced pancreatic cancer: A randomized phase II trial (TCOG T5217)
Chiang, N. J., Su, Y. Y., Ho, I. W., Bai, L. Y., Li, C. P., Chen, J. S., Hsiao, C. F., Tsou, H. H., Hsu, C., Chiu, T. J., Hsieh, Y. Y., Rau, K. M., Ho, C. L., Shan, Y. S. & Chen, L. T., 2月 25 2026, 於: European Journal of Cancer. 235, 116229.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines
Yen, C. C., Wu, I. C., Yu, C. C., Chen, M. H., Chiang, N. J., Fang, W. L., Chen, K. H., Chen, C. C., Hong, T. C., Chen, Y. C., Wong, M. W., Chan, D. C., Chen, I. S., Chen, Y. Y., Liu, Y. W., Wu, J. M., Chou, W. C., Yang, C. K., Hsu, J. T. & Yeh, T. S. 及其他11, , 2026, 於: Gastric Cancer.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
開啟存取 -
A phase 1 study of fixed-dose regimens of serplulimab, an anti-PD-1 antibody, in patients with advanced solid tumors.
Ho, C. L., Chao, T. Y., Wu, S. Y., Chang, C. L., Lin, H. Y., Yang, F., Shen, Y., Yu, H. & Wang, Q., 6月 2025, 於: Journal of Clinical Oncology. 43, 16, p. 2596 1 p.研究成果: 雜誌貢獻 › 回顧型文獻 › 同行評審
資料集
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
Liu, T.-P. (Contributor), Yang, P.-M. (Creator), Hsieh, Y.-Y. (Creator) & Chou, C.-J. (Contributor), The Royal Society, 2018
DOI: 10.6084/m9.figshare.7346312.v2, https://doi.org/10.6084%2Fm9.figshare.7346312.v2
資料集: Dataset
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I.-C. (Contributor), Lai, G.-M. (Contributor), Chow, J.-M. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Li, C.-H. (Contributor), Yan, J.-L. (Contributor), Chuang, S.-E. (Contributor), Whang-Peng, J. (Creator), Bai, K.-J. (Contributor) & Yao, C.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
資料集: Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J.-M. (Contributor), Yan, J.-L. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Lai, I.-C. (Contributor), Yao, C.-J. (Contributor), Lai, G.-M. (Contributor), Bai, K.-J. (Contributor), Chuang, S.-E. (Contributor) & Li, C.-H. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
資料集: Dataset